{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:41:25Z","timestamp":1790174485989,"version":"4.1.0"},"reference-count":69,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Saudi Med"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.5144\/0256-4947.1998.412","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T14:24:02Z","timestamp":1494512642000},"page":"412-416","source":"Crossref","is-referenced-by-count":7,"title":["Recent Trends in the Treatment of Cutaneous Leishmaniasis"],"prefix":"10.5144","volume":"18","author":[{"given":"Abdulaziz","family":"Alkhawajah","sequence":"first","affiliation":[{"name":"From the Department of Pharmacology, College of Medicine, King Faisal University, Dammam, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3134","reference":[{"key":"e_1_3_1_2_2","volume-title":"The leishmaniases: World Health Organization Technical Report Series 701","author":"World Health Organization (WHO) Report of Expert Committee","year":"1984"},{"key":"e_1_3_1_3_2","first-page":"333","article-title":"The leishmaniases: a public health problem in Saudi Arabia","volume":"8","author":"Peters W","year":"1987","journal-title":"Saudi Med J"},{"key":"e_1_3_1_4_2","volume-title":"TDR\/LEISH\/CL-JER\/83.3","author":"World Health Organization","year":"1983"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0733-8635(18)30604-1","article-title":"Leishmaniasis","volume":"7","author":"Kubba R","year":"1989","journal-title":"Dermatol Clin"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.1976.tb04375.x","article-title":"Tropical dermatology","volume":"94","author":"Bryceson ADM","year":"1976","journal-title":"Br J Dermatol"},{"key":"e_1_3_1_7_2","first-page":"139","article-title":"New aspects on cutaneous leishmaniasis","volume":"5","author":"Stratigos JD","year":"1980","journal-title":"Dermatosen"},{"key":"e_1_3_1_8_2","first-page":"425","article-title":"Contribution to the progress of antimony therapy of Kala-azar","volume":"52","author":"Kikuth W","year":"1937","journal-title":"Chinese Med J"},{"key":"e_1_3_1_9_2","first-page":"399","article-title":"Traitement du Kala-azar par un nouveau campose stibie: 2, 168 RP (premiers resultats)","volume":"62","author":"Durand P","year":"1946","journal-title":"Bull Mem Soc Med Bop Paris"},{"key":"e_1_3_1_10_2","first-page":"439","volume-title":"HMSO","year":"1973"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/00034983.1963.11686192","article-title":"The effects of two antimony drugs on the in vitro metabolism of radioactive glucose forms of Leishmania tropica","volume":"57","author":"Voller A","year":"1963","journal-title":"Ann Trop Med Parasitol"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/AAC.27.6.916","article-title":"Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate","volume":"27","author":"Berman JD","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/infdis\/142.1.83","article-title":"An in vitro model for investigation of chemotherapeutic agents in leishmaniasis","volume":"142","author":"Berman JD","year":"1980","journal-title":"J Infec Dis"},{"key":"e_1_3_1_14_2","first-page":"119","article-title":"Visceral leishmaniasis (kala azar) in Fars province, Iran: study of 130 cases","volume":"83","author":"Hashemi-Nasab A","year":"1980","journal-title":"J Trop Med Hyg"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (pentostam) versus ketoconazole for treating cutaneous leishmanisis in Guatemala","volume":"165","author":"Navin T","year":"1992","journal-title":"J Infec Dis"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/jama.1974.03230350028021","article-title":"American cutaneous leishmaniasis: inefficacy of metronidazole in treatment","volume":"228","author":"Walto BC","year":"1974","journal-title":"JAMA"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.1973.03230080020006","article-title":"Leishmaniasis in the United States: a report of ten cases in military personnel","volume":"226","author":"Kern F","year":"1973","journal-title":"JAMA"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1185\/03007997909109438","article-title":"Evaluation of sodium stibogluconate in the treatment of cutaneous leishmainasis in Syria","volume":"6","author":"Ghosh S","year":"1979","journal-title":"Curr Med Res Opin"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"Chulay JD","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(87)93053-4","article-title":"Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis","volume":"2","author":"Ballou WR","year":"1987","journal-title":"Lancet"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/00034983.1997.11813217","article-title":"Treatment of cutaneous leishmaniasis with antimony: intramuscular vs intralesional administration","volume":"91","author":"Alkhawaja AM","year":"1997","journal-title":"Ann Trop Med Parasitol"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0035-9203(85)90199-3","article-title":"Visceral leishmaniasis unresponsive to antimonial drugs II: response to high-dose sodium stibogluconate or prolonged treatment with pentamidine","volume":"79","author":"Bryceson ADM","year":"1985","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4269\/ajtmh.1985.34.710","article-title":"High continuous antimony therapy in two patients with unresponsive mucocutaneous leishmaniasis","volume":"34","author":"Marsden PD","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4269\/ajtmh.1985.34.856","article-title":"American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules","volume":"34","author":"Oster CN","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_1_25_2","first-page":"34","article-title":"Antimonials","author":"World Health Organization","year":"1990","journal-title":"Large scale failure in leishmaniasis \u201calarming.\u201d TDR news"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/00034983.1977.11687174","article-title":"The ultrastructural changes of Leishmania tropica after treatment with pentamidine","volume":"71","author":"Hentzer B","year":"1977","journal-title":"Ann Trop Med Para"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0035-9203(70)90173-2","article-title":"Diffuse cutaneous leishmaniasis: treatment","volume":"64","author":"Bryceson AD","year":"1970","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"e_1_3_1_28_2","first-page":"20","article-title":"Chemotherapy of leishmanial diseases: a resume of recent researches","volume":"88","author":"Sen Gupta PC","year":"1953","journal-title":"Ind Med Gazette"},{"key":"e_1_3_1_29_2","first-page":"110","article-title":"Pentamidine-induced diabetes mellitus","volume":"45","author":"Bryceson ADM","year":"1968","journal-title":"East Afr Med J"},{"key":"e_1_3_1_30_2","first-page":"596","article-title":"Ketoconazole in cutaneous leishmaniasis: results of a pilot study","volume":"7","author":"Kubba R","year":"1986","journal-title":"Saudi Med J"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman JD","year":"1997","journal-title":"Clin Infect Dis"},{"key":"e_1_3_1_32_2","first-page":"288","article-title":"Cutaneous leishmaniasis treatment with ketoconazole","volume":"32","author":"Weinrauch L","year":"1983","journal-title":"Cutis"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-4362.1982.tb03163.x","article-title":"Oral ketoconazole in the treatment of leishmaniasis","volume":"21","author":"Urcuyo FG","year":"1982","journal-title":"Int J Dermatol"},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2230.1986.tb00425.x","article-title":"Cutaneous leishmaniasis from Belize: treatment with ketoconazole","volume":"11","author":"Jollife DS","year":"1986","journal-title":"Clin Exp Dermatol"},{"key":"e_1_3_1_35_2","first-page":"14","article-title":"Evaluation of topical ketoconazole in CL","volume":"69","author":"Abahusein A","year":"1992","journal-title":"East Afr Med J"},{"key":"e_1_3_1_36_2","first-page":"1058","article-title":"Hepatitis and ketoconazole therapy","volume":"283","author":"Macnair AL","year":"1981","journal-title":"Br Med J"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-4362.1994.tb01049.x","article-title":"Treatment of cutaneous leishmaniasis with oral itraconazole","volume":"33","author":"Van den Enden E","year":"1994","journal-title":"Int J Dermatol"},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archderm.1975.01630220107012","article-title":"Metronidazole therapy for cutaneous leishmaniasis","volume":"111","author":"Pearson JK","year":"1975","journal-title":"Arch Dermatol"},{"key":"e_1_3_1_39_2","first-page":"61","article-title":"Treatment of Mexican cutaneous leishmaniasis with metronidazole","volume":"70","author":"Beltran HF","year":"1967","journal-title":"Bull Soc Pathol Exot"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.1978.tb06181.x","article-title":"Failure of metronidazole treatment in Ethiopian mucocutaneous leishmaniasis","volume":"99","author":"Belehu A","year":"1978","journal-title":"Br J Dermatol"},{"key":"e_1_3_1_41_2","first-page":"815","volume-title":"Cecil Textbook of Medicine","author":"Bryceson ADM","year":"1980"},{"key":"e_1_3_1_42_2","first-page":"184","volume-title":"Clinical tropical diseases","author":"Maegrath B","year":"1980","edition":"7"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-4362.1967.tb05251.x","article-title":"The treatment of leishmaniasis residuals with local injections of amphotericin B","volume":"6","author":"Ganor S","year":"1967","journal-title":"Dermatol Int"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","article-title":"Allopurinol in the treatment of American cutaneous leishmaniasis","volume":"326","author":"Martinez S","year":"1992","journal-title":"N Engl J Med"},{"key":"e_1_3_1_45_2","first-page":"159","article-title":"Rifampicin in the treatment of cutaneous leishmaniasis","volume":"6","author":"Selim MM","year":"1972","journal-title":"J Kuwait Med Assoc"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-4362.1986.tb03435.x","article-title":"Dapsone in the treatment of cutaneous leishmaniasis","volume":"25","author":"Dogra J","year":"1986","journal-title":"Int J Dermatol"},{"key":"e_1_3_1_47_2","first-page":"270","volume-title":"Tropical and Geographical Medicine","author":"Wyler DJ","year":"1984"},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0035-9203(81)90086-9","article-title":"Further trials of nifurtimox in mucocutaneous leishmaniasis","volume":"75","author":"Guena MFV","year":"1981","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0035-9203(38)90097-5","article-title":"Early discoveries regarding the parasites of Oriental sore","volume":"32","author":"Hoare CA","year":"1938","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/bmj.287.6399.1105-a","article-title":"Treatment of cutaneous leishmaniasis by curretage","volume":"287","author":"Currie MA","year":"1983","journal-title":"Br Med J"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1524-4725.1983.tb01055.x","article-title":"Early surgical treatment of cutaneous leishmaniasis","volume":"9","author":"Azab AS","year":"1983","journal-title":"J Dermatol Surg Oncol"},{"key":"e_1_3_1_52_2","first-page":"388","article-title":"Cutaneous leishmaniasis","volume":"3","author":"Griffiths WAD","year":"1980","journal-title":"Postgrad Doctor Mid East"},{"key":"e_1_3_1_53_2","first-page":"302","article-title":"Effect of temperature on multiplication of leishmania amastigotes within human monocyte-derived macrophages in vitro","volume":"149","author":"Berman JD","year":"1981","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4362.1986.tb03460.x","article-title":"Treatment of cutaneous leishmaniasis with infra-red heat","volume":"25","author":"Junaid AJN","year":"1986","journal-title":"Int J Dermatol"},{"key":"e_1_3_1_55_2","first-page":"68","article-title":"Alternate treatment of cutaneous leishmaniasis","volume":"51","author":"Mutinga MJ","year":"1974","journal-title":"East Afr Med J"},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2133.1982.tb00390.x","article-title":"Cryotherapy in cutaneous leishmaniasis","volume":"107","author":"Bassiony A","year":"1982","journal-title":"Br J Dermatol"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-4362.1989.tb04814.x","article-title":"Dissemination in cutaneous leishmaniasis 3: lymph node involvement","volume":"28","author":"Al-Gindan Y","year":"1989","journal-title":"Int J Dermatol"},{"key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.1988.tb07100.x","article-title":"Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony","volume":"119","author":"Sharquie KE","year":"1988","journal-title":"Br J Dermatol"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0190-9622(86)70214-4","article-title":"Treatment of cutaneous leishmaniasis with an intralesional antimony drug (Pentostam)","volume":"15","author":"Kellum RE","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_60_2","first-page":"433","article-title":"Cutaneous leishmaniasis from Yemen: treatment with intralesional injection of sodium stibogluconate with local anesthetic","volume":"18","author":"Al-Qubati Y","year":"1997","journal-title":"Saudi Med J"},{"key":"e_1_3_1_61_2","first-page":"620","article-title":"Topical treatment with imidazoles for cutaneous leishmaniasis","volume":"15","author":"Brenner S","year":"1985","journal-title":"Isr J Med Sci"},{"key":"e_1_3_1_62_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4269\/ajtmh.1995.52.166","article-title":"A randomized, double-blind clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the Eastern Province of Saudi Arabia","volume":"52","author":"Larbi EM","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0169-4758(88)90200-1","article-title":"Topical chemotherapy of cutaneous leishmaniasis","volume":"4","author":"El-On J","year":"1988","journal-title":"Parasitol Today"},{"key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4269\/ajtmh.1986.35.1110","article-title":"Leishmania major: antileishmanial activity of methylbenzethonium chloride","volume":"35","author":"El-On J","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_1_65_2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0035-9203(90)90146-6","article-title":"A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment","volume":"84","author":"El-Safi SH","year":"1990","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"e_1_3_1_66_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-4362.1984.tb05669.x","article-title":"Combination of sodium stibogluconate and rifampicin in cutaneous leishmaniasis","volume":"23","author":"Pareek SS","year":"1984","journal-title":"Int J Dermatol"},{"key":"e_1_3_1_67_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-4362.1983.tb02117.x","article-title":"Therapeutic effect of rifampicin and isoniazid against L. major","volume":"22","author":"Livshin R","year":"1983","journal-title":"Int J Dermatol"},{"key":"e_1_3_1_68_2","first-page":"401","article-title":"Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis","volume":"1","author":"Jacinto C","year":"1987","journal-title":"Lancet"},{"key":"e_1_3_1_69_2","first-page":"274","article-title":"Open field trial of short course of liposomal amphotericin B in complicated visceral leishmaniasis","volume":"49","author":"Seaman J","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_1_70_2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4269\/ajtmh.1993.48.666","article-title":"Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon gamma","author":"Squires KA","year":"1993","journal-title":"Am J Trop Med Hyg"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annsaudimed.net\/index.php\/vol18\/vol18iss5\/2851.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T10:58:18Z","timestamp":1559473098000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.1998.412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.5144\/0256-4947.1998.412"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.1998.412","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}